Table 2.

Drug-resistance markers in OC identified by MS-based proteomic techniques

Chemoresistance markers	MS technique	Ref.
Annexin 3; Destrin; Cofilin1; Gluthathione-S transferase omega 1; Cytosolic NADP+ dependent isocitrate dehydrogenase	MALDI-TOF	[87]
ATP synthase subunit alpha; Peroxiredoxin 3; Prohibitin; Electron transfer flavoprotein subunit alpha; Aldehyde dehydrogenase X	MALDI-TOF	[88]
ERp57	MALDI-TOF ESI-Q-TOF	[89]
Tumor rejection antigen (gp96) 1; Triose phosphate isomerase; Palmitoyl-protein thioesterase1 precursor; ER-associated DNAJ	MALDI-TOF ESI-Q-TOF	[91]
Aldehyde dehydrogenase 1 family, member A1; Annexin A1; Heterogeneous Nuclear Ribonucleoproteins A2; Rho GDP dissociation inhibitor	MALDI-TOF LC-MS/MS	[90]
Activated leukocyte cell adhesion molecule; A kinase anchoring protein 12; Nestin	Orbitrap	[92]
Thioredoxin domain containing 17	Orbitrap	[93]
Mitochondrial topoisomerase I	Orbitrap	[94]
Cell recognition molecule CASPR3; S100 protein family members; Junction adhesion molecule Claudin 4; CDC42-binding protein kinase beta	ESI-MS/MS	[95]
P53 binding protein 1; Catenin delta 1 and plakoglobin; EGF-containing fibulin-like extracellular matrix protein 1; Voltage-dependent anion-selective channel protein 1	HPLC-ESI-MS/MS	[96]
Pyruvate kinase isozymes M1/M2; Heat Shock Protein Family D	ESI-Q-TOF	[97]